COVID-19 Rapid Antigen Test

Product Advantages

The COVID-19 Rapid Antigen Test is a point-of-care kit designed for the
detection of SARS-CoV-2 antigens in direct nasal swab samples.

The test is intended for use by healthcare professionals in symptomatic individuals
within 5 days after onset of symptoms.

This product has received FDA Emergency Use Authorization.

  • Fast: Results in 20 minutes
  • Convenient: No equipment or training needed
  • Simple Sampling: Self-collected shallow nasal samples Batch
  • Testing: Easily collect and test multiple samples

Intuitive Workflow

Batch Testing

Intuitive design allows for the
concurrent collection of a large
number of samples followed by
batch testing of individual
samples within 2 hours.

Clinical Performance

In a prospective US clinical study, we accurately identified 84% of
those who were positive (PPA) and 97%of those who were negative
(NPA) for SARS-CoV-2.

Product performance against variants of concern are evaluated on an
ongoing basis.

Technical Bulletin available upon request.

Authorized Distributor:
North American
Diagnostics, LLC

info@covidantibodydiagnostics.com
https://covidantibodydiagnostics.com/

The test is authorized for laboratory and point of care use (e.g., doctors office, mobile clinics, student clinics, pharmacies)

 

The test needs to be performed by medical assistant, laboratory technician, registered nurse, licensed vocational nurse, licensed phlebotomist, pharmacist etc.

 

Each site requires a CLIA certificate to perform CLIA waived tests